Improving health through evidence-based probiotics
Winclove Probiotics, established in Amsterdam, The Netherlands, has been specializing in research, development and manufacturing of probiotic formulations for over 25 years.
In close collaboration with business partners, research institutes and universities hospitals we develop evidence-based, indication-specific probiotics for a variety of indications. Our probiotic formulations enable people worldwide to improve their health in a natural way.
Research is the foundation of our probiotic formulations. Our employees, specializing in different microbiota- and probiotic related fields, are engaged in international multidisciplinary projects focused on the microbiota in health and disease. This enables us to develop innovative multispecies probiotic formulations for many different health indications.
We continuously invest in research and technologies in order to develop the most effective probiotics and more importantly, to ensure that the end-user is provided with the best solution.
Our product development is based on identifying key alterations in the microbiome that are associated with specific diseases. We use this knowledge combined with our proprietary library of over 100 well-studied microbial strains, to develop indication-specific probiotic formulation that restore the microbial balance. We offer probiotic therapies for traditional GI therapeutic indications as well as more innovative areas, such as; women’s health, mental health and upper respiratory tract infections.